Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Glowing dye could spot hidden esophageal cancers early

NCT ID NCT05745857

First seen May 02, 2026 · Last updated May 24, 2026 · Updated 2 times

Summary

This study tests a new imaging method called quantitative fluorescence molecular endoscopy (qFME) to find early cancerous changes in the esophagus of people with Barrett's esophagus. Participants will receive two fluorescent dyes (bevacizumab-800CW and cetuximab-800CW) either by mouth or applied directly to the esophagus during an endoscopy. The goal is to see if this technique can spot lesions that standard white-light endoscopy might miss, improving early detection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Medical Center Groningen

    RECRUITING

    Groningen, Provincie Groningen, 9713 GZ, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.